Halozyme Therapeutics Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Karyopharm Therapeutics, Blueprint Medicines and Agenus.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. |  Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | |
Founding Date | Founding Date 1998 | Founding Date 2008 | Founding Date 2011 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Newton, US HQ Givatayim, IL | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US |
Employees | Employees 373157% increase | Employees 32516% decrease | Employees 6552% increase | Employees 38927% decrease |
Valuation ($) | Valuation ($) 6.4 b | Valuation ($) 111.7 m | Valuation ($) 5.3 b | Valuation ($) 96.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $1b (FY, 2024) | Revenue (est.) $145.2m (FY, 2024) | Revenue (est.) $508.8m (FY, 2024) | Revenue (est.) $156.3m (FY, 2023) |
Cost of goods | Cost of goods $159.4m (FY, 2024) | Cost of goods N/A | Cost of goods $20.2m (FY, 2024) | Cost of goods $3.1m (FY, 2023) |
Gross profit | Gross profit $855.9m (FY, 2024) | Gross profit N/A | Gross profit $488.7m (FY, 2024) | Gross profit $153.2m (FY, 2023) |
Net income | Net income $444.1m (FY, 2024) | Net income ($76.4m) (FY, 2024) | Net income ($67.1m) (FY, 2024) | Net income ($257.4m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 171.9m | Total funding raised $ 248.7m | Total funding raised $ 1.7b | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
Karyopharm Therapeutics
HQ
Newton, US
Employees
325↓ 16% decrease
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
View companyBlueprint Medicines
HQ
Cambridge, US
Employees
655↑ 2% increase
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
View companyAgenus
HQ
Lexington, US
Employees
389↓ 27% decrease
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company